Mesoblast MESO
NASDAQ MESO
$13.96 -0.48 (-3.32%)
As of: Nov 10, 2026 · 2:16 PM EST

Mesoblast (MESO) Raw Materials (2024 - 2026)

Updated

Mesoblast (MESO) posted Raw Materials of $15.81 million for the quarter ended Jun 30, 2026, compared with $1.06 million a year earlier.

Analysis

Mesoblast (MESO) Raw Materials (2024 - 2026) Analysis & Trends

Since the quarter ended Dec 31, 2024, Mesoblast has reported Raw Materials for 4 quarters.

  • In prior years, Mesoblast's Raw Materials was $1.06 million in the year ended Jun 30, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Mesoblast 1.84 Bn 1.40 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.81 Mn
Dec 31, 2025 6.11 Mn
Jun 30, 2025 1.06 Mn
Dec 31, 2024 946,000.00
API Access

Mesoblast Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=MESO&period=max&api_key=YOUR_API_KEY